Advisors Asset Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-733
Closed -$42K 1594
2017
Q1
$42K Sell
733
-439
-37% -$26.2K ﹤0.01% 1457
2016
Q4
$72K Sell
1,172
-236
-17% -$15.4K ﹤0.01% 1605
2016
Q3
$97K Sell
1,408
-168
-11% -$11.1K ﹤0.01% 1522
2016
Q2
$88K Sell
1,576
-168
-10% -$10.1K ﹤0.01% 1537
2016
Q1
$106K Sell
1,744
-174
-9% -$10.2K ﹤0.01% 1447
2015
Q4
$123K Buy
1,918
+254
+15% +$16.5K ﹤0.01% 1498
2015
Q3
$112K Buy
1,664
+526
+46% +$37.2K ﹤0.01% 1494
2015
Q2
$78K Buy
+1,138
New +$72.2K ﹤0.01% 1613

Other funds holding USNA

Advisors Asset Management's USNA Position: Q2 2017 in Review

Advisors Asset Management sold out of Usana Health Sciences (USNA) in Q2 2017, closing a stake of 733 shares — an estimated $42K sold.

Advisors Asset Management first reported a position in USNA in Q2 2015 and held it in 8 quarters. The position peaked at $123K in Q4 2015. 145 funds tracked by Wall St. Rank hold USNA as of Q2 2017.

  • Advisors Asset Management reported no remaining Usana Health Sciences position as of Q2 2017 after selling out during the quarter.
  • Advisors Asset Management sold 733 Usana Health Sciences shares in Q2 2017, an estimated $42K.
  • Advisors Asset Management first reported a position in Usana Health Sciences in Q2 2015 and held it in 8 quarters.
  • Advisors Asset Management's Usana Health Sciences position peaked at $123K in Q4 2015.
  • 145 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2017.

Based on Advisors Asset Management's 13F filing for Q2 2017, filed 2 Aug 2017.